This site is intended for healthcare professionals
Drug news

AstraZeneca and Merck Inc., to collaborate on Lynparza (olaparib) for multiple cancer types and on selumetinib.

Read time: 1 mins
Last updated:14th Aug 2017
Published:28th Jul 2017
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest